https://www.gov.uk/government/publications/jcvi-interim-advice-on-a-potential-coronavirus-covid-19-booster-vaccine-programme-for-winter-2021-to-2022<\/a><\/p>The JCVI\u2019s interim advice is that COVID-19 boosters should first be offered to the most vulnerable. The JCVI advises a two staged approach, with individuals in Stage 1 offered a COVID-19 booster vaccine, and flu vaccine, as soon as possible from September, and individuals in Stage 2 offered a COVID-19 booster vaccine as soon as practicable after Stage 1, with equal emphasis on deployment of the flu vaccine where eligible.<\/p>
Final decisions on the timing and scope and cohort eligibility, including the groups listed above, of any COVID-19 vaccine booster\u202fprogramme will be confirmed once the JCVI have provided their final advice, alongside considerations related to COVID-19 vaccine supply and approvals by the Medicines and Healthcare products Regulatory Agency.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4113", "label" : {"_value" : "Biography information for Nadhim Zahawi"}
}
, "answeringMemberConstituency" : {"_value" : "Stratford-on-Avon"}
, "answeringMemberPrinted" : {"_value" : "Nadhim Zahawi"}
, "dateOfAnswer" : {"_value" : "2021-09-10", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2021-09-10T13:46:11.66Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2021-09-07", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Coronavirus: Vaccination"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what plans his Department has for a covid-19 vaccine booster campaign in autumn 2021.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4385", "label" : {"_value" : "Biography information for Dr Philippa Whitford"}
}
, "tablingMemberConstituency" : {"_value" : "Central Ayrshire"}
, "tablingMemberPrinted" : [{"_value" : "Dr Philippa Whitford"}
], "uin" : "44364"}
, {"_about" : "http://data.parliament.uk/resources/1353507", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1353507/answer", "answerText" : {"_value" : "
The National Institute for Health Research has commissioned the National Immunisation Schedule Evaluation Consortium to undertake the Com-CoV trial. This trial is gathering data on the long-term immune response of using different COVID-19 vaccines for the first and second dose.<\/p>
Public Health England has also undertaken follow up on people given mixed schedules as part of routine care to monitor self-reported side effects and antibody response. The antibody results will be published in due course.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4113", "label" : {"_value" : "Biography information for Nadhim Zahawi"}
}
, "answeringMemberConstituency" : {"_value" : "Stratford-on-Avon"}
, "answeringMemberPrinted" : {"_value" : "Nadhim Zahawi"}
, "dateOfAnswer" : {"_value" : "2021-09-10", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2021-09-10T09:07:39.593Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2021-09-07", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Coronavirus: Vaccination"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what steps his Department has taken to ensure long term monitoring of immunity in people who have received different covid-19 vaccines for each dose.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4385", "label" : {"_value" : "Biography information for Dr Philippa Whitford"}
}
, "tablingMemberConstituency" : {"_value" : "Central Ayrshire"}
, "tablingMemberPrinted" : [{"_value" : "Dr Philippa Whitford"}
], "uin" : "44365"}
, {"_about" : "http://data.parliament.uk/resources/1353563", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1353563/answer", "answerText" : {"_value" : "
Work is underway to determine which non-Medicines and Healthcare products Regulatory Agency authorised vaccines we will recognise with confidence to enable United Kingdom residents vaccinated abroad to demonstrate their vaccination status. A solution will be rolled out in England as a pilot from the end of September.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4113", "label" : {"_value" : "Biography information for Nadhim Zahawi"}
}
, "answeringMemberConstituency" : {"_value" : "Stratford-on-Avon"}
, "answeringMemberPrinted" : {"_value" : "Nadhim Zahawi"}
, "dateOfAnswer" : {"_value" : "2021-09-13", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2021-09-13T16:36:09.48Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2021-09-07", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Coronavirus Certificates: British Nationals Abroad"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 30 July 2021 to Question 31551, when UK residents vaccinated against covid-19 while overseas with a (a) Pfizer, (b) Oxford-AstraZeneca and (c) Moderna vaccine are able to be certified as vaccinated by the UK.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/3912", "label" : {"_value" : "Biography information for Richard Fuller"}
}
, "tablingMemberConstituency" : {"_value" : "North East Bedfordshire"}
, "tablingMemberPrinted" : [{"_value" : "Richard Fuller"}
], "uin" : "44282"}
, {"_about" : "http://data.parliament.uk/resources/1353571", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1353571/answer", "answerText" : {"_value" : "
The Department has published an impact statement detailing the expected effect of the vaccination as a condition of deployment policy on care homes. The department will publish a full impact assessment in due course. We continue to monitor the impact of the policy on care homes as we approach 11 November.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4113", "label" : {"_value" : "Biography information for Nadhim Zahawi"}
}
, "answeringMemberConstituency" : {"_value" : "Stratford-on-Avon"}
, "answeringMemberPrinted" : {"_value" : "Nadhim Zahawi"}
, "dateOfAnswer" : {"_value" : "2021-09-10", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2021-09-10T13:48:13.347Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2021-09-07", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Care Homes: Coronavirus"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what assessment he has made of the effect of the policy that staff at CQC-registered care homes must have received both covid-19 doses from 11 November 2021 on staffing levels in those homes.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4591", "label" : {"_value" : "Biography information for Sarah Olney"}
}
, "tablingMemberConstituency" : {"_value" : "Richmond Park"}
, "tablingMemberPrinted" : [{"_value" : "Sarah Olney"}
], "uin" : "44423"}
, {"_about" : "http://data.parliament.uk/resources/1353594", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1353594/answer", "answerText" : {"_value" : "
Although the overall risk from COVID-19 in pregnant women is low, in later pregnancy some women may become seriously unwell and need hospital treatment. Pregnant women with COVID-19 have a higher risk of intensive care admission than women of the same age who are not pregnant. Women with COVID-19 disease are also 2-3 times more likely to have their babies early than women without COVID-19. Pregnant women with underlying clinical conditions are at even higher risk of suffering serious complications from COVID-19.<\/p>
<\/p>
Currently, the Joint Committee on Vaccination and Immunisation (JCVI) recommends an interval of 8 weeks between doses of all the available COVID-19 vaccines; this includes pregnant women. It is important to note that current evidence shows that a longer dose interval produces a better immune response. The JCVI regularly reviews its advice in relation to COVID-19 Vaccination Programme, taking into account new data and evidence on the effectiveness of the programme and epidemiological situation.<\/p>
<\/p>
We are working hard to drive uptake in pregnant women, to ensure that as many pregnant women take up the offer of vaccination as soon as possible so that they are protected throughout their pregnancy. It is understood that pregnant women may prefer to wait to be vaccinated until after they have given birth. It is important for pregnant women to discuss their offer of vaccination with a healthcare professional in relation to the risks and benefits of the vaccine.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4113", "label" : {"_value" : "Biography information for Nadhim Zahawi"}
}
, "answeringMemberConstituency" : {"_value" : "Stratford-on-Avon"}
, "answeringMemberPrinted" : {"_value" : "Nadhim Zahawi"}
, "dateOfAnswer" : {"_value" : "2021-09-10", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2021-09-10T13:44:02.607Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2021-09-07", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Pregnancy: Coronavirus"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what assessment he has made of the risk covid-19 poses to unvaccinated pregnant women; and what steps he is taking to ensure pregnant women receive both doses of the vaccine before their third trimester.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4510", "label" : {"_value" : "Biography information for Helen Hayes"}
}
, "tablingMemberConstituency" : {"_value" : "Dulwich and West Norwood"}
, "tablingMemberPrinted" : [{"_value" : "Helen Hayes"}
], "uin" : "44411"}
, {"_about" : "http://data.parliament.uk/resources/1353595", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1353595/answer", "answerText" : {"_value" : "
Currently, the Joint Committee on Vaccination and Immunisation (JCVI) recommends an interval of eight weeks between doses of all the available COVID-19 vaccines; this includes pregnant women. On 14 May 2021, in response to the increasing rates of infection of the Delta variant, the Government amended the interval of second doses for the most vulnerable cohorts who were offered a vaccine in phase one of the programme, from 12 weeks to an eight-week gap. The eight-week dose interval was applied to all eligible cohorts from 6 July.<\/p>
It should be noted that current evidence shows that a longer dose interval produces a better immune response. As such, the JCVI has advised against reducing the dose interval further in order to maximise the effectiveness of the vaccination programme. The JCVI regularly reviews its advice in relation to COVID-19 vaccinations, taking into account new data and evidence on the effectiveness of the programme and the ongoing epidemiological situation.<\/em><\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4113", "label" : {"_value" : "Biography information for Nadhim Zahawi"}
}
, "answeringMemberConstituency" : {"_value" : "Stratford-on-Avon"}
, "answeringMemberPrinted" : {"_value" : "Nadhim Zahawi"}
, "dateOfAnswer" : {"_value" : "2021-09-13", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2021-09-13T10:26:14.233Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2021-09-07", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Pregnancy: Coronavirus"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential merits of bringing forward pregnant women's second doses of the covid-19 vaccine before their third trimester.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4510", "label" : {"_value" : "Biography information for Helen Hayes"}
}
, "tablingMemberConstituency" : {"_value" : "Dulwich and West Norwood"}
, "tablingMemberPrinted" : [{"_value" : "Helen Hayes"}
], "uin" : "44412"}
, {"_about" : "http://data.parliament.uk/resources/1352871", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1352871/answer", "answerText" : {"_value" : "The information requested is not currently centrally held. Work is ongoing across the vaccination programme to standardise and increase the information available for management purposes.<\/p>
We have put in place robust mitigations throughout the vaccination programme to reduce wastage, manage expiry dates, and avoid vaccine destruction.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4113", "label" : {"_value" : "Biography information for Nadhim Zahawi"}
}
, "answeringMemberConstituency" : {"_value" : "Stratford-on-Avon"}
, "answeringMemberPrinted" : {"_value" : "Nadhim Zahawi"}
, "dateOfAnswer" : {"_value" : "2021-09-10", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2021-09-10T11:00:27.323Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2021-09-06", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Coronavirus: Vaccination"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, how many covid-19 vaccines have been disposed of that were (a) out of date (b) unused to date.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4658", "label" : {"_value" : "Biography information for Alex Sobel"}
}
, "tablingMemberConstituency" : {"_value" : "Leeds North West"}
, "tablingMemberPrinted" : [{"_value" : "Alex Sobel"}
], "uin" : "43653"}
, {"_about" : "http://data.parliament.uk/resources/1352957", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1352957/answer", "answerText" : {"_value" : "
It is not known how long antibodies made in response to natural COVID-19 infection persist, and whether immunisation could offer more protection. However, it is expected the COVID-19 vaccine would boost any pre-existing antibodies from previous infection. There is no evidence of any safety concerns from vaccinating individuals with a history of COVID-19 infection or with detectable antibodies to COVID-19. Therefore, people who have had COVID-19 disease \u2013 whether confirmed or suspected \u2013 should still receive the COVID-19 vaccine.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4113", "label" : {"_value" : "Biography information for Nadhim Zahawi"}
}
, "answeringMemberConstituency" : {"_value" : "Stratford-on-Avon"}
, "answeringMemberPrinted" : {"_value" : "Nadhim Zahawi"}
, "dateOfAnswer" : {"_value" : "2021-09-10", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2021-09-10T09:12:09.827Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2021-09-06", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Coronavirus: Vaccination"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what evidence his Department holds on the potential benefits of immunisation against covid-19 for people who have previously tested positive for that virus.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4645", "label" : {"_value" : "Biography information for Emma Hardy"}
}
, "tablingMemberConstituency" : {"_value" : "Kingston upon Hull West and Hessle"}
, "tablingMemberPrinted" : [{"_value" : "Emma Hardy"}
], "uin" : "43644"}
, {"_about" : "http://data.parliament.uk/resources/1353027", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1353027/answer", "answerText" : {"_value" : "
The Joint Committee on Vaccination and Immunisation\u2019s advice on vaccination of those aged 16 to 17 years old was published on 4 August 2021. The statement sets out the basis for the advice and includes references to supporting evidence and is available at the following link:<\/p>
https://www.gov.uk/government/publications/jcvi-statement-august-2021-covid-19-vaccination-of-children-and-young-people-aged-12-to-17-years<\/a><\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4113", "label" : {"_value" : "Biography information for Nadhim Zahawi"}
}
, "answeringMemberConstituency" : {"_value" : "Stratford-on-Avon"}
, "answeringMemberPrinted" : {"_value" : "Nadhim Zahawi"}
, "dateOfAnswer" : {"_value" : "2021-09-09", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2021-09-09T16:39:03.13Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2021-09-06", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Coronavirus: Vaccination"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, if he will publish the data and evidential basis which supports the decision of the Joint Committee on Vaccination and Immunisation to authorise administration of a covid-19 vaccine to people aged 16 and 17.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4000", "label" : {"_value" : "Biography information for Ian Mearns"}
}
, "tablingMemberConstituency" : {"_value" : "Gateshead"}
, "tablingMemberPrinted" : [{"_value" : "Ian Mearns"}
], "uin" : "43491"}
], "itemsPerPage" : 10, "next" : "https://eldaddp.azurewebsites.net/answeredquestions.text?_page=1&min-date=2019-06-14&answer.answeringMemberConstituency=Stratford-on-Avon&answeringDeptSortName=Health+and+Social+Care&min-ddpModified.=2020-11-17T20%3A47%3A09.184Z", "page" : 0, "startIndex" : 1, "totalResults" : 1304, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]}
}